Global Prosthetic Heart Valve & Artificial Heart Valve Market Growth 2024-2030

Global Prosthetic Heart Valve & Artificial Heart Valve Market Growth 2024-2030

The global Prosthetic Heart Valve & Artificial Heart Valve market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Prosthetic Heart Valve & Artificial Heart Valve Industry Forecast” looks at past sales and reviews total world Prosthetic Heart Valve & Artificial Heart Valve sales in 2023, providing a comprehensive analysis by region and market sector of projected Prosthetic Heart Valve & Artificial Heart Valve sales for 2024 through 2030. With Prosthetic Heart Valve & Artificial Heart Valve sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prosthetic Heart Valve & Artificial Heart Valve industry.

This Insight Report provides a comprehensive analysis of the global Prosthetic Heart Valve & Artificial Heart Valve landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prosthetic Heart Valve & Artificial Heart Valve portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prosthetic Heart Valve & Artificial Heart Valve market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prosthetic Heart Valve & Artificial Heart Valve and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prosthetic Heart Valve & Artificial Heart Valve.

United States market for Prosthetic Heart Valve & Artificial Heart Valve is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Prosthetic Heart Valve & Artificial Heart Valve is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Prosthetic Heart Valve & Artificial Heart Valve is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Prosthetic Heart Valve & Artificial Heart Valve players cover Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc.(Abbott Laboratories Company), Boston Scientific Corporation and Livanova Plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Prosthetic Heart Valve & Artificial Heart Valve market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Transcatheter Heart Valve
Tissue Heart Valve
Mechanical Heart Valve

Segmentation by application
Rheumatic Heart Disease
Congenital Heart Disease
Marfan Syndrome
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences Corporation
Medtronic Plc
St. Jude Medical Inc.(Abbott Laboratories Company)
Boston Scientific Corporation
Livanova Plc
Symetis
Jenavalve Technology Inc.
Cryolife Inc.
Ttk Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional Devices
Autotissue Berlin Gmbh
Comed B.V.
Meril Life Sciences
Labcor Laboratório
HLT Inc.(A Bracco Group Company)
Medtronic
Edwards Lifesciences Corporation
Boston Scientific Corporation
Livanova Plc
St. Jude Medical, Inc.(An Abbott Laboratories Company)
Symetis Sa
Jenavalve Technology, Inc.
Cryolife, Inc.
TTK Healthcare Limited(A Ttk Group Company)
Colibri Heart Valve, Llc
Lepu Medical Technology Co., Ltd.
Braile Biomédica

Key Questions Addressed in this Report

What is the 10-year outlook for the global Prosthetic Heart Valve & Artificial Heart Valve market?

What factors are driving Prosthetic Heart Valve & Artificial Heart Valve market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Prosthetic Heart Valve & Artificial Heart Valve market opportunities vary by end market size?

How does Prosthetic Heart Valve & Artificial Heart Valve break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.